Lv2
144 积分 2024-08-19 加入
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
4小时前
已完结
CAR T-cell therapy in autoimmune diseases
1天前
已完结
Bullous and Exanthematous Lesions Associated With Chimeric Antigen Receptor T-Cell Therapy in a Patient With Diffuse Large B-Cell Lymphoma
1天前
已完结
New and future therapies: Changes in the therapeutic armamentarium for SLE
2天前
已完结
Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis
3天前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
3天前
已完结
Immunotherapy of melanoma
1个月前
已完结
Anti-PD-L1 antibody reverses the immune tolerance induced by multiple MUC1-MBP vaccine immunizations by increasing the CD80/PD-L1 ratio, resulting in DC maturation, and decreasing Treg activity in B16-MUC1 melanoma-bearing mice
1个月前
已完结
Clinical Features and Outcomes of Black Patients With Melanoma
1个月前
已完结
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
1个月前
已完结
皖公网安备34019202002308
